OraSure Technologies | OSUR - Interest Expense On Debt


OraSure Technologies reported 1.67M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Agilent USD 25M 2M Dec/2025
AngioDynamics USD 102K 2K Sep/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Bio Techne USD 2.17M 9K Dec/2025
Bio-Rad Laboratories USD 12.1M 200K Dec/2025
Bruker USD 8.1M 11.9M Dec/2025
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Danaher USD 63M 8M Mar/2026
Dentsply International USD 24M 2M Mar/2026
Dexcom USD 4.2M 500K Dec/2025
Illumina USD 26M 1000K Dec/2025
Integra LifeSciences USD 22.46M 1.21M Mar/2026
Intuitive Surgical USD 20.11B 58.39B Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
Mettler Toledo International USD 17.39M 307K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.58M 83K Mar/2026
Revvity USD 24.72M 1.2M Mar/2026
STAAR Surgical USD 800K 799K Sep/2025
Thermo Fisher Scientific USD 354M 11M Mar/2026
Trinity Biotech USD 3.33M 50K Sep/2025
Waters USD 42M 33.38M Mar/2026